BrainStorm Cell

Petah Tikva, Israel Founded: 2000 • Age: 26 yrs
Developer ofstem cell therapies for the treatment of neurodegenerative diseases such as ALS, MS, PD
Request Access

About BrainStorm Cell

BrainStorm Cell is a company based in Petah Tikva (Israel) founded in 2000.. The company has 27 employees as of December 31, 2024. BrainStorm Cell offers products and services including NurOwn. BrainStorm Cell operates in a competitive market with competitors including Mesoblast, RoosterBio, SanBio, Osiris and SCM Lifescience, among others.

  • Headquarter Petah Tikva, Israel
  • Employees 27 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Brainstorm Cell Therapeutics Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $0
    0
    as on Dec 31, 2024
  • Net Profit
    $-11.62 M
    32.39
    as on Dec 31, 2024
  • EBITDA
    $-11.45 M
    45.91
    as on Dec 31, 2024
  • Latest Funding Round
    $500 K (USD), Grant

    Jun 09, 2020

  • Investors
  • Employee Count
    27

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of BrainStorm Cell

BrainStorm Cell is a publicly listed company on the OTC with ticker symbol BCLI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OTC · Ticker: BCLI . Sector: Health technology · USA

Products & Services of BrainStorm Cell

BrainStorm Cell offers a comprehensive portfolio of products and services, including NurOwn. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Investigational platform for producing autologous MSC-NTF cells for neurodegenerative diseases.

People of BrainStorm Cell
Headcount 10-50
Employee Profiles 15
Board Members and Advisors 1
Employee Profiles
People
Uri Yablonka
EVP, Chief Business Officer
People
Bob Dagher
Executive Vice President & Chief Medical Officer
People
Alex Burshtein
Quality Assurance Manager
People
Keren Mizrahi
Senior Scientist

Unlock access to complete

Board Members and Advisors
people
Stacy Lindborg
Board Member

Unlock access to complete

Funding Insights of BrainStorm Cell

  • Total Funding
  • Total Rounds 9
  • Last Round Grant — $500,000
  • First Round

    (27 Jul 2012)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2020 Amount Grant - BrainStorm Cell Valuation

investors

Apr, 2020 Amount Grant - BrainStorm Cell Valuation

investors

Nov, 2019 Amount Grant - BrainStorm Cell Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BrainStorm Cell

BrainStorm Cell has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include National MS Society, Israel Innovation Authority and I AM ALS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
A non-profit organization focused on ALS support and advocacy is operated.
Founded Year Domain Location
-
Founded Year Domain Location
Business development in Israel is supported by a government organization.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BrainStorm Cell

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BrainStorm Cell

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Brainstorm Cell Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BrainStorm Cell

BrainStorm Cell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mesoblast, RoosterBio, SanBio, Osiris and SCM Lifescience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biotherapeutics derived from proprietary adult stem cell-based technologies
domain founded_year HQ Location
Developer of human mesenchymal stem cells and extracellular vesicles
domain founded_year HQ Location
Regenerative cell medicines for neurological disorders are developed.
domain founded_year HQ Location
Stem cell-based regenerative medicines are developed and marketed.
domain founded_year HQ Location
Mesenchymal stem cells are developed for therapeutics using proprietary methods.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Brainstorm Cell

Frequently Asked Questions about BrainStorm Cell

When was BrainStorm Cell founded?

BrainStorm Cell was founded in 2000 and raised its 1st funding round 12 years after it was founded.

Where is BrainStorm Cell located?

BrainStorm Cell is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.

Who is the current CEO of BrainStorm Cell?

Chaim Lebovits is the current CEO of BrainStorm Cell.

How many employees does BrainStorm Cell have?

As of Dec 31, 2024, the latest employee count at BrainStorm Cell is 27.

What does BrainStorm Cell do?

BrainStorm Cell Therapeutics was founded in 2000 in Petah Tikva, Israel, within the biotechnology sector. Autologous stem cell therapies are developed for neurodegenerative disorders such as ALS, multiple sclerosis, and Parkinsons disease. The NurOwn platform is utilized to differentiate mesenchymal stem cells into neurotrophic factor-secreting cells for transplantation near affected sites. Animal models of these diseases, including Huntingtons and peripheral nerve injury, are employed in research and testing.

Who are the top competitors of BrainStorm Cell?

BrainStorm Cell's top competitors include RoosterBio, Mesoblast and SanBio.

What products or services does BrainStorm Cell offer?

BrainStorm Cell offers NurOwn.

Is BrainStorm Cell publicly traded?

Yes, BrainStorm Cell is publicly traded on OTC under the ticker symbol BCLI.

Who are BrainStorm Cell's investors?

BrainStorm Cell has 5 investors. Key investors include National MS Society, Israel Innovation Authority, I AM ALS, ALS Association, and Portalsaude.

What is BrainStorm Cell's ticker symbol?

The ticker symbol of BrainStorm Cell is BCLI on OTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available